Development of a novel in vitro 3D intestinal model for permeability evaluations

References

• Al-Ali AAA, Steffansen B, Holm R, Nielsen CU. 2018. Nonionic surfactants increase digoxin absorption in Caco-2 and MDCKII MDR1 cells: impact on P-glycoprotein inhibition, barrier function, and repeated cellular exposure. Int J Pharm. 551(1–2):270–280.
   PubMed Web of Science ®Google Scholar
• Allen JD, Van Loevezijn A, Lakhai JM, Van Der Valk M, Van Tellingen O, Reid G, Schellens JH, Koomen GJ, Schinkel AH. 2002. Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C 1. Mol Cancer Ther. 1(6):417–425.
   PubMed Web of Science ®Google Scholar
• Anderle P, Niederer E, Rubas W, Hilgendorf C, Spahn-Langguth H, Wunderli-Allenspach H, Merkle HP, Langguth P. 1998. P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. J Pharm Sci. 87(6):757–762.
   PubMed Web of Science ®Google Scholar
• Antunes F, Andrade F, Araújo F, Ferreira D, Sarmento B. 2013. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs. Eur J Pharm Biopharm. 83(3):427–435.
   PubMed Web of Science ®Google Scholar
• Artursson P, Karlsson J. 1991. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 175(3):880–885.
   PubMed Web of Science ®Google Scholar
• Artursson P, Ungell AL, Löfroth JE. 1993. Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments. Pharm Res. 10(8):1123–1129.
   PubMed Web of Science ®Google Scholar
• Balda MS, Fallon MB, Van Itallie CM, Anderson JM. 1992. Structure, regulation, and pathophysiology of tight junctions in the gastrointestinal tract. Yale J Biol Med. 65(6):725–740.
   PubMed Web of Science ®Google Scholar
• Basson MD, Turowski GA, Rashid Z, Hong F, Madri JA. 1996. Regulation of human colonic cell line proliferation and phenotype by sodium butyrate. Digest Dis Sci. 41(10):1986–1993.
   Web of Science ®Google Scholar
• Bhagwate S, Gaikwad NJ. 2013. Stability indicating HPLC method for the determination of hydrochlorothiazide in pharmaceutical dosage form. J Appl Pharm Sci. 3:88–92.
   Google Scholar
• Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem. 72(1–2):248–254.
   PubMed Web of Science ®Google Scholar
• Charde M, Welankiwar AS. 2014. Development of validated RP-HPLC method for the simultaneous estimation of atenolol and chlorthalidone in combine tablet dosage form. Int J Adv Pharm. 3:6–18.
   Google Scholar
• DiMarco RL, Hunt DR, Dewi RE, Heilshorn SC. 2017. Improvement of paracellular transport in the Caco-2 drug screening model using protein-engineered substrates. Biomaterials. 129:152–162.
   PubMed Web of Science ®Google Scholar
• Drygiannakis I, Valatas V, Sfakianaki O, Bourikas L, Manousou P, Kambas K, Ritis K, Kolios G, Kouroumalis E. 2013. Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosis. J Crohn's Colitis. 7(4):286–300.
   Google Scholar
• Ebner T, Ishiguro N, Taub ME. 2015. The use of transporter probe drug cocktails for the assessment of transporter-based drug–drug interactions in a clinical setting—proposal of a four component transporter cocktail. J Pharm Sci. 104(9):3220–3228.
   PubMed Web of Science ®Google Scholar
• Eneroth A, Åström E, Hoogstraate J, Schrenk D, Conrad S, Kauffmann HM, Gjellan KE. 2001. Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction. Eur J Pharm Sci. 12(3):205–214.
   PubMed Web of Science ®Google Scholar
• Estudante M, Morais JG, Soveral G, Benet LZ. 2013. Intestinal drug transporters: an overview. Adv Drug Deliv Rev. 65(10):1340–1356.
   PubMed Web of Science ®Google Scholar
• Faralli A, Shekarforoush E, Ajalloueian F, Mendes AC, Chronakis IS. 2019. In vitro permeability enhancement of curcumin across Caco-2 cells monolayers using electrospun xanthan-chitosan nanofibers. Carbohydr Polym. 206:38–47.
   PubMed Web of Science ®Google Scholar
• Felton JS, Jägerstad M, Knize MG, Skog K, Wakabayashi K. 2000. Contents in foods, beverages and tobacco. In: Nagao M, Sugimura T, editors. Food borne carcinogens heterocyclic amines. Chichester, England: John Wiley & Sons Ltd.; p. 31–71.
   Google Scholar
• Flecknell P. 2002. Replacement, reduction, refinement. ALTEX-Alternat Animal Exp. 19(2):73–78.
   Google Scholar
• Furuya K, Sokabe M, Furuya S. 2005a. Characteristics of subepithelial fibroblasts as a mechano-sensor in the intestine: cell-shape-dependent ATP release and P2Y1 signaling. J Cell Sci. 118(15):3289–3304.
   PubMed Web of Science ®Google Scholar
• Furuya S, Furuya K, Sokabe M, Hiroe T, Ozaki T. 2005b. Characteristics of cultured subepithelial fibroblasts in the rat small intestine. II. Localization and functional analysis of endothelin receptors and cell-shape-independent gap junction permeability. Cell Tissue Res. 319(1):103–119.
   PubMed Web of Science ®Google Scholar
• García-Rodríguez A, Vila L, Cortés C, Hernández A, Marcos R. 2018. Effects of differently shaped TiO2 NPs (nanospheres, nanorods and nanowires) on the in vitro model (Caco-2/HT29) of the intestinal barrier. Part Fibre Toxicol. 15(1):33.
   PubMedGoogle Scholar
• Hidalgo IJ, Raub TJ, Borchardt RT. 1989. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 96(2):736–749.
   PubMedGoogle Scholar
• Hymery N, Mounier J, Coton E. 2018. Effect of Penicillium roqueforti mycotoxins on Caco-2 cells: acute and chronic exposure. Toxicol in Vitro. 48:188–194.
   PubMed Web of Science ®Google Scholar
• Isshiki M, Umezawa K, Tamura H. 2011. Coffee induces breast cancer resistance protein expression in Caco-2 cells. Biol Pharm Bull. 34(10):1624–1627.
   PubMed Web of Science ®Google Scholar
• Kenny AJ, Maroux S. 1982. Topology of microvillar membrance hydrolases of kidney and intestine. Physiol Rev. 62(1):91–128.
   PubMed Web of Science ®Google Scholar
• Knize MG, Felton JS. 2005. Formation and human risk of carcinogenic heterocyclic amines formed from natural precursors in meat. Nutr Rev. 63(5):158–165.
   PubMed Web of Science ®Google Scholar
• Korjamo T, Honkakoski P, Toppinen MR, Niva S, Reinisalo M, Palmgrén JJ, Mönkkönen J. 2005. Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines. Eur J Pharm Sci. 26(3–4):266–279.
   PubMed Web of Science ®Google Scholar
• Kowapradit J, Opanasopit P, Ngawhirunpat T, Apirakaramwong A, Rojanarata T, Ruktanonchai U, Sajomsang W. 2010. In vitro permeability enhancement in intestinal epithelial cells (Caco-2) monolayer of water soluble quaternary ammonium chitosan derivatives. AAPS PharmSciTech. 11(2):497–508.
   PubMed Web of Science ®Google Scholar
• Le Ferrec E, Chesne C, Artusson P, Brayden D, Fabre G, Gires P, Guillou F, Rousset M, Rubas W, Scarino ML. 2001. In vitro models of the intestinal barrier. Atla. 29:649–668.
   Google Scholar
• Leonard F, Collnot EM, Lehr CM. 2010. A three-dimensional coculture of enterocytes, monocytes and dendritic cells to model inflamed intestinal mucosa in vitro. Mol Pharm. 7(6):2103–2119.
   PubMedGoogle Scholar
• Levin VA. 1980. Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability. J Med Chem. 23(6):682–684.
   PubMed Web of Science ®Google Scholar
• Li N, Wang D, Sui Z, Qi X, Ji L, Wang X, Yang L. 2013. Development of an improved three-dimensional in vitro intestinal mucosa model for drug absorption evaluation. Tissue Eng Part C: Methods. 19(9):708–719.
   PubMed Web of Science ®Google Scholar
• Maubon N, Le Vee M, Fossati L, Audry M, Le Ferrec E, Bolze S, Fardel O. 2007. Analysis of drug transporter expression in human intestinal Caco‐2 cells by real‐time PCR. Fundam Clin Pharmacol. 21:659–663.
   PubMed Web of Science ®Google Scholar
• Murakami T, Takano M. 2008. Intestinal efflux transporters and drug absorption. Expert Opin Drug Metab Toxicol. 4(7):923–939.
   PubMed Web of Science ®Google Scholar
• Owens B M J, Simmons A. 2013. Intestinal stromal cells in mucosal immunity and homeostasis. Mucosal Immunol. 6(2):224.
   PubMed Web of Science ®Google Scholar
• Pan F, Han L, Zhang Y, Yu Y, Liu J. 2015. Optimization of Caco-2 and HT29 co-culture in vitro cell models for permeability studies. Int J Food Sci Nutr. 66(6):680–685.
   PubMed Web of Science ®Google Scholar
• Patil S, Kumar L, Kohli G, Bansal A. 2012. Validated HPLC method for concurrent determination of antipyrine, carbamazepine, furosemide and phenytoin and its application in assessment of drug permeability through Caco-2 cell monolayers. Sci Pharm. 80(1):89–100.
   PubMedGoogle Scholar
• Penny JI, Campbell FC. 1994. Active transport of benzo[a]pyrene in apical membrane vesicles from normal human intestinal epithelium. Biochim Biophys Acta. 1226(2):232–236.
   PubMed Web of Science ®Google Scholar
• Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. 1999a. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol – Cell Physiol. 277(1):C1–C19.
   Web of Science ®Google Scholar
• Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. 1999b. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol – Cell Physiol. 277(2):C183–C201.
   Web of Science ®Google Scholar
• Rhayat L, Maresca M, Nicoletti C, Perrier J, Brinch KS, Christian S, Devillard E, Eckhardt E. 2019. Effect of Bacillus subtilis strains on intestinal barrier function and inflammatory response. Front Immunol. 10:564.
   PubMed Web of Science ®Google Scholar
• Rubas W, Cromwell M, Gadek T, Narindray D, Mrsny R. 1993. Structural elements which govern the resistance of intestinal tissues to compound transport. MRS Online Proc Library Archive. 331:179.
   Google Scholar
• Samy KE, Levy ES, Phong K, Demaree B, Abate AR, Desai TA. 2019. Human intestinal spheroids cultured using sacrificial micromolding as a model system for studying drug transport. Sci Rep. 9(1):1–12.
   PubMedGoogle Scholar
• Schinkel AH, Jonker J W. 2012. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev. 64:138–153.
   PubMed Web of Science ®Google Scholar
• Schweinlin M, Wilhelm S, Schwedhelm I, Hansmann J, Rietscher R, Jurowich C, Walles H, Metzger M. 2016. Development of an advanced primary human in vitro model of the small intestine. Tissue Eng Part C: Methods. 22(9):873–883.
   PubMed Web of Science ®Google Scholar
• Shen J, Wanwimolruk S. 1991. A simple and sensitive HPLC method for antipyrine in plasma. J Liquid Chromatogr. 14(14):2801–2808.
   Web of Science ®Google Scholar
• Skolnik S, Lin X, Wang J, Chen XH, He T, Zhang B. 2010. Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay. J Pharm Sci. 99(7):3246–3265.
   PubMed Web of Science ®Google Scholar
• Sobue K, Yamamoto N, Yoneda K, Hodgson ME, Yamashiro K, Tsuruoka N, Tsuda T, Katsuya H, Miura Y, Asai K, et al. 1999. Induction of blood–brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors. Neurosci Res. 35(2):155–164.
   PubMed Web of Science ®Google Scholar
• Srikanth MV, Ram BJ, Sunil SA, Rao NS, Murthy KV. 2012. Development and validation of HPLC method for estimation of propranolol HCl in human plasma. JSIR. 71:120–123.
   Google Scholar
• Srinivasan B, Kolli AR, Esch MB, Abaci HE, Shuler ML, Hickman JJ. 2015. TEER measurement techniques for in vitro barrier model systems. J Lab Autom. 20(2):107–126.
   PubMedGoogle Scholar
• Srivastava M, Kohli K, Ali M. 2014. Stability indicating RP-HPLC method for analysis of ketoprofen in bulk drug and eugenol containing nanoemulsion gel (NEG) formulation using response surface methodology. Curr Pharm Anal. 10(2):135–144.
   Web of Science ®Google Scholar
• Stockdale TP, Challinor VL, Lehmann RP, De Voss JJ, Blanchfield JT. 2019. Caco-2 monolayer permeability and stability of Chamaelirium luteum (false unicorn) open-chain steroidal saponins. ACS Omega. 4(4):7658–7666.
   Web of Science ®Google Scholar
• Sultana N, Arayne MS, Siddiqui R, Naveed S. 2012. RP-HPLC method for the simultaneous determination of lisinopril and NSAIDs in API, pharmaceutical formulations and human serum. Am J Anal Chem. 03(02):147–152.
   Google Scholar
• Tajerzadeh H, Hamidi M. 2001. A simple HPLC method for quantitation of enalaprilat. J Pharm Biomed Anal. 24(4):675–680.
   PubMed Web of Science ®Google Scholar
• Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC. 2011. Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. 141(5):769–776.
   PubMed Web of Science ®Google Scholar
• Wu JJ, Zhu YF, Guo ZZ, Lou YM, He SG, Guan Y, Zhu LJ, Liu ZQ, Lu LL, Liu L. 2018. Aconitum alkaloids, the major components of Aconitum species, affect expression of multidrug resistance-associated protein 2 and breast cancer resistance protein by activating the Nrf2-mediated signalling pathway. Phytomedicine. 44:87–97.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zheng Y, Chow MS, Zuo Z. 2004. Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int J Pharm. 287(1–2):1–12.
   PubMedGoogle Scholar
• Zucco F, Batto A-F, Bises G, Chambaz J, Chiusolo A, Consalvo R, Cross H, Dal Negro G, de Angelis I, Fabre G, et al. 2005. An inter-laboratory study to evaluate the effects of medium composition on the differentiation and barrier function of Caco-2 cell lines. Altern Lab Anim. 33(6):603–618.
   PubMed Web of Science ®Google Scholar